Innovative biotech stocks have a good chance of breaking out in 2025

The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…

Novartis CEO says it won't join weight-loss drug frenzy

The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…